The novel and patented bioceramic platforms are based on ceramic biomaterials with tunable nanostructures. The technology enables the distribution of active substances in bioceramic materials, and the active substance is then released to achieve the right effect by controlled diffusion.
The bioceramic materials have bio-compatible properties, making them safe to use and providing regulatory advantages.
The release and dosage of the active substances can be tuned by adjusting the size of the pores, choice of actual biomaterial, and the excipients used. By applying the bioceramic platforms, Emplicure aims to improve patients’ quality of life through new and innovative products.
Amplicon is initially developing new products for the nicotine market by applying the same platforms, improving release profiles of taste and nicotine.